Target intelligence / Profile preview

17-beta-hydroxysteroid dehydrogenase type 2 (HSD17B2) (HSD17B2)

Target
HSD17B2
Molecular classification
Enzyme, Oxidoreductase, Short-chain dehydrogenase/reductase (SDR) family
01

Overview

17-beta-hydroxysteroid dehydrogenase type 2 (17β-HSD2) is a membrane-bound enzyme belonging to the short-chain dehydrogenase/reductase (SDR) family that plays a critical role in the local regulation of steroid hormone activity [1, 6]. It primarily functions as an oxidoreductase, catalyzing the conversion of potent 17β-hydroxysteroids, such as estradiol and testosterone, into their less active 17-keto forms, estrone and androstenedione, respectively [1, 11]. By inactivating these hormones, 17β-HSD2 protects tissues from excessive estrogenic or androgenic stimulation [12, 14]. The enzyme is widely expressed in tissues including the liver, intestines, endometrium, and bone, where it modulates the microenvironment's hormonal balance [1, 15]. In clinical contexts, 17β-HSD2 is a significant therapeutic target for osteoporosis, as its inhibition can locally increase estradiol and testosterone levels in bone to promote bone mineral density [8, 12, 16]. Conversely, its deficient expression in the endometrium is a hallmark of endometriosis, leading to an accumulation of estradiol that drives lesion growth [12, 17]. In oncology, 17β-HSD2 expression levels serve as prognostic biomarkers in breast, prostate, and lung cancers, where altered activity influences tumor progression and response to endocrine therapies [9, 18, 21]. Current drug development efforts focus on identifying selective, non-steroidal inhibitors that can provide bone-specific benefits while minimizing systemic side effects [16, 19, 31].

Other names
17-beta-HSD 220 alpha-hydroxysteroid dehydrogenaseE2DHEstradiol 17-beta-dehydrogenase 2Microsomal 17-beta-hydroxysteroid dehydrogenaseShort chain dehydrogenase/reductase family 9C member 2Testosterone 17-beta-dehydrogenaseHSD17SDR9C2
02

Mechanism of action

Inhibition of 17-beta-hydroxysteroid dehydrogenase type 2 prevents the oxidative inactivation of potent steroids like estradiol and testosterone, thereby increasing their local concentrations in target tissues such as bone to stimulate bone formation and inhibit resorption.

03

Biological functions

Steroid metabolismInactivation of estrogensInactivation of androgensActivation of progestogensRegulation of local hormone bioavailability
04

Disease associations

OsteoporosisEndometriosisBreast cancerProstate cancerGastric cancerNon-small cell lung cancer
05

Safety considerations

Lack of selectivity against other HSD17B isoformsPotential for systemic estrogenic side effects (e.g., endometrial hyperplasia)Tissue-specific delivery challenges
06

Interacting drugs

HSD17B2 inhibitors (experimental)
07

Biomarkers

HSD17B2 mRNA expressionHSD17B2 protein expression (IHC)HSD17B1/HSD17B2 expression ratioOsteoprotegerin (OPG)

Beyond the preview

Go deeper on 17-beta-hydroxysteroid dehydrogenase type 2 (HSD17B2) (HSD17B2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 17-beta-hydroxysteroid dehydrogenase type 2 (HSD17B2) (HSD17B2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call